Acta Neuropathologica

, Volume 82, Issue 1, pp 60–65

P2-peptide induced experimental allergic neuritis: a model to study axonal degeneration

Authors

  • A. F. Hahn
    • Department of Clinical Neurological SciencesUniversity of Western Ontario, Victoria Hospital
  • T. E. Feasby
    • Department of Clinical Neurological SciencesUniversity of Western Ontario, Victoria Hospital
  • L. Wilkie
    • Department of Clinical Neurological SciencesUniversity of Western Ontario, Victoria Hospital
  • D. Lovgren
    • Department of Clinical Neurological SciencesUniversity of Western Ontario, Victoria Hospital
Regular Papers

DOI: 10.1007/BF00310924

Cite this article as:
Hahn, A.F., Feasby, T.E., Wilkie, L. et al. Acta Neuropathol (1991) 82: 60. doi:10.1007/BF00310924

Summary

In experimental allergic neuritis (EAN) severity of clincal disease and pathology correlate with the dose of antigen (Hahn et al., Lab Invest 59:115–125, 1988). To avoid axonal membrane contamination of the antigen, EAN was induced with a synthetic peptide, corresponding to residues 53–78 of bovine P2 myelin protein. Severity of EAN correlated with the dose of peptide in the inoculate. The relationship between demyelination, inflammation and axonal degeneration was studied. Low doses resulted in pure demyelination. Axonal degeneration occurred only with high doses of inflammation. The role of macrophages in producing axonal damage is discussed.

Key words

Experimental allergic neuritis: P2 myelin peptideDemyelinationAxonal degeneration

Copyright information

© Springer-Verlag 1991